ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1364

Accelerated Diastolic Dysfunction in Premenopausal Women with Rheumatoid Arthritis

Yune-Jung Park1, JiHee Kim2, Ki-Jo Kim3, Wan-Uk Kim4, Chul-Soo Cho5, Kyung-Su Park6 and Ki-Dong Yoo2, 1Internal Medicine, St. Vincent's Hospital, The Catholic University of Korea, Suwon, South Korea, 2Division of Cardiology, Department of Internal Medicine, St.Vincent’s Hospital, The Catholic University of Korea, Suwon, Republic of Korea, Suwon, South Korea, 3Internal Medicine, St. Vincent’s Hospital, The Catholic University of Korea, Suwon, South Korea, 4Internal Medicine, Seoul St. Mary’s Hospital, The Catholic University of Korea, Seoul, South Korea, 5Internal Medicine, Yeouido St. Mary's Hospital, The Catholic University of Korea, Seoul, South Korea, 6Division of Rheumatology, Department of Internal Medicine, School of Medicine, The Catholic University of Korea, Seoul, South Korea

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Cardiovascular disease and rheumatoid arthritis (RA)

  • Tweet
  • Email
  • Print
Session Information

Title: Rheumatoid Arthritis - Clinical Aspects (ACR): Comorbidities, Treatment Outcomes and Mortality

Session Type: Abstract Submissions (ACR)

Background/Purpose: Disturbances of diastolic function precede systolic heart failure and, although clinically silent, represent the earliest sign of cardiac involvement. Diastolic dysfunction is associated with age, female, and hypertension. However, little is known about the age-specific incidence rates and risk factors for diastolic dysfunction in patients with rheumatoid arthritis (RA).

Methods: We used standard two-dimensional/Doppler echocardiography to screen for the presence of diastolic dysfunction in 61 patients with RA (mean [±SD] age, 48.1±7.9 years) and 107 healthy subjects (47.3±9.4 years). All participants were premenopausal women with no history of hypertension. Diastolic dysfunction was defined as impaired relaxation with or without increased filling pressures.

Results: The two groups were similar with respect to age (P=0.269). Patients with RA had significantly higher LV mass index, LV filling pressure, and lower E/A velocity than controls. All patients had preserved ejection fraction (EF ≥50%). Diastolic dysfunction was more common in patients with RA at 47% compared with 26% in the controls (P=0.004). Women with RA in the 30- to 49- year age group were over 3.5 times more likely to have diastolic dysfunction than those of similar age in the control group (OR=3.54; 95% CI 1.27 to 9.85). Among patients with RA, high CRP levels were independently associated with diastolic dysfunction even after adjustment for cardiovascular risk factors (P=0.009).

Conclusion: In premenopausal women with RA, diastolic dysfunction is much more common and the age at onset is reduced. Early screening of myocardial function may provide an opportunity for preventing future cardiovascular disease.


Disclosure:

Y. J. Park,
None;

J. Kim,
None;

K. J. Kim,
None;

W. U. Kim,
None;

C. S. Cho,
None;

K. S. Park,
None;

K. D. Yoo,
None.

  • Tweet
  • Email
  • Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/accelerated-diastolic-dysfunction-in-premenopausal-women-with-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology